Insights & Resources

Is your transaction a business combination or asset acquisition? Learn how ASC 805 guidance, the screen test and key differences shape reporting.

Texas life sciences in 2025 saw concentrated capital, declining innovation output and earlier‑stage clinical shifts shaping the ecosystem.

Get ahead of the curve by looking back at emerging trends in 2025 that are likely to impact health care valuation in 2026 and beyond. Download Weaver Insights now.

Texas life sciences saw record capital in Q4 2025, even as innovation, early-stage funding and late-phase clinical trials continued to decline.

Divorce misconceptions can complicate cases. Weaver shows how clear financial records help clarify assets, support fair outcomes and reduce conflict.

PET, CT and MRI volumes are accelerating. Learn what uneven imaging growth means for valuation and long-term planning.

Growth strategies in behavioral health are shifting. Learn how leaders can respond to industry headwinds and optimize performance effectively.

Premarital and LLC agreements can override statutory defaults in divorce valuations. The In re S.R.W. case shows how they reshape economic interests.

Explore Q3 2025 trends in Texas life sciences, from Series B collapse and pipeline bottlenecks to sector divergence and record late-stage capital.

Learn why ESOP audits matter, common pitfalls to avoid and how proactive communication and valuation reviews can strengthen plan integrity.

After divorce, financial obligations continue. Forensic accountants help ensure compliance, transparency and long-term stability.

Colleges face rising fraud from “ghost students.” Learn how to detect fake enrollments, strengthen controls and protect aid funds.